The fourth in our series of Women in Advanced Therapies interviews. This is a very special episode in the series, in which Jana Stoudmire interviews Emily Whitehead, the first child patient of Novartis’ Kymriah treatment.
In this episode we’re delighted to be interviewing Emily Whitehead, cancer survivor and ambassador for CAR-T therapy. At only six-years-old, Emily Whitehead was facing a life-threatening recurrence of acute lymphoblastic leukemia, the most common childhood cancer.
Emily’s cancer resisted over 16 months of chemotherapy treatments when her parents were told that her cancer had relapsed and that she would not survive. Jana Stoudemire exclusively interviews Emily, alongside her father Tom.
Praying for Emily: The Faith, Science, and Miracles That Saved Our Daughter is available now on hardback – https://www.amazon.co.uk/Praying-Emily
Check out Tom and Anthony’s fireside chat ‘The Patient’s Eye View of the Kymriah Story’ from Phacilitate Leaders World 2019 – click to see the interview.
As always, we hope you’ve enjoyed the episode. Please share your feedback with us and let us know what you’d like us to discuss in the next series of Phacilitate Talks.